Browse > Article
http://dx.doi.org/10.13048/jkm.13006

Anti-thrombotic Effects of Modified Jeho-tang using a $FeCl_3$-induced Carotid Arterial Thrombosis Model  

Bang, Jihye (KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine)
Lee, Ki Mo (KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine)
Kim, Bu-Yeo (KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine)
Lee, Jeong-Hwa (Literature&Informatics Research division, Korea Institute of Oriental Medicine)
Lee, In Sun (KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine)
Jeon, Won Kyung (KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine)
Publication Information
The Journal of Korean Medicine / v.34, no.2, 2013 , pp. 51-58 More about this Journal
Abstract
Objectives: The aim of this study was to examine the antithrombotic effects of the four herbal ingredients (Mume Fructus, MF; Santali Albi Lignum, SAL; Amomi Tsao-Ko Fructus, ATF; and Amomi Fructus, AF) of modified Jeho-tang (MJHT) in a ferric chloride ($FeCl_3$)-induced carotid arterial thrombosis model. Methods: Thirty minutes prior to a 35% $FeCl_3$ application, Sprague-Dawley (SD) rats were injected with saline, MF, SAL, ATF or AF (100 mg/kg, intraperitoneal injection), respectively. The effect of the MJHT ingredients was examined for time to occlusion (TTO) and thrombus weight (TW) in a $FeCl_3$-induced thrombosis model. Histological analysis was performed to examine the effect of the MJHT ingredients on collagen fiber damage using hematoxylin & eosin and Masson's trichrome staining. Results: Compared with vehicle treatment, MF, SAL and ATF treatment delayed TTO (vehicle, $8.11{\pm}0.60$ min; MF, $16.67{\pm}1.03$ min; SAL, $17.50{\pm}1.52$ min and ATF, $13.33{\pm}1.21$ min; P < 0.001) and inhibited thrombus formation (vehicle, $0.79{\pm}0.03$ mg/mm; MF, $0.61{\pm}0.07$ mg/mm; SAL, $0.57{\pm}0.03$ mg/mm and ATF, $0.72{\pm}0.02$ mg/mm; P < 0.001). In addition, each herbal ingredient of MJHT except for AF prevented the collagen fiber damage induced by a 35% $FeCl_3$ application. These results indicate that the MJHT ingredients MF ${\geq}$ SAL ${\geq}$ ATF ${\geq}$ AF possess antithrombotic activity in a $FeCl_3$-induced carotid arterial thrombosis. Conclusions: Altogether, these results are the first evidence that the MJHT ingredients MF, SAL and ATF have the ability to prevent vascular damage and thrombus formation in $FeCl_3$-induced carotid arterial thrombosis.
Keywords
modified Jeho-tang; $FeCl_3$-induced carotid arterial rat model; thrombosis;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Heo EJ, Lee IS, Kang HW, Jeon WK. Effects of Sokmyong-tang on Ferric choliride-induced carotid injury thrombosis in a rat model. Korean J Oriental Physiology & Pathology. 2012; 26(5):732-7.
2 Lee IS, Chio SG, Jeon WK. Optimization of ferric chloride induced carotid artery thrombosis model in a rat: Effect of Ginkgo biloba extracts. The Korean Journal of Clinical Laboratory Sciences. 2011; 43(4):179-87.
3 Fuster V, Kelly BB. Promoting cardiovascular health in the developing world (A critical challenge to achieve global health). Institute of Medicine (US) Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries. National Academies Press, Washington (DC). 2010; 275-7.
4 Kim KS, Shin YW, Kim EI, Kim SM, Lee JE, Yoo DY. The experimental study on antithrombotic activities of Wuslsan. The Journal of Oriental Obstetrics & Gynecology. 2005;18(3):110-26.
5 Sachs UJ, Nieswandt B. In vivo thrombus formation in murine models. Circ Res. 2007; 100(7):979-91.   DOI   ScienceOn
6 Lee IS, Kim MY, Jeon WK. Acute toxicity study of Modified Jeho-tang in ICR mice. The Korean Journal of clinical Laboratory Sciences. 2012; 44(2):59-64.
7 Renne T, Pozgajova M, Gruner S, Schuh K, Pauer HU, Burfeind P, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med. 2005; 202(2):271-81.   DOI   ScienceOn
8 Owens AP, Mackman N. Tissue factor and thrombosis: The clot starts here. Thromb Haemost. 2010;104(3): 432-9.   DOI   ScienceOn
9 Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature. 2008;451(7181):904-13.   DOI   ScienceOn
10 Baek KM, Roh SS. Effects of Aqueous extract of diospyros Kaki Calyx on ant-thrombotic activity in vitro and in vivo. Kor J Herblology. 2011;26(4):139-47.
11 Leadley Jr RJ, Chi L, Rebello SS, Gagnon A. Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. J Pharmacol Toxicol Methods. 2000;43(2):101-16.   DOI   ScienceOn
12 Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res. 1990; 60(4):269-80.   DOI   ScienceOn
13 Iwatsuki Y, Kawasaki T, Hayashi K, Moritani Y, Nii T, Miyata K. Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIA antagonist YM128 on thrombosis and neointima formation in mice. Thromb Haemost. 2004; 92(6):1221-8.
14 Konstantinides S, Schafer K, Thinnes T, Loskutoff DJ. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation . 2001;103(4):576-83.   DOI   ScienceOn
15 Elg M, Gustafsson D, Carlsson S. Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat. Thromb Res. 1999; 94(3):187-97.   DOI   ScienceOn
16 Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, Chen YC, et al. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ Res. 2006; 99(1):25-33.   DOI   ScienceOn
17 Nishida M, Mastsuno H, Kozawa O, Ueshima S, Matsuo O, Collen D, et al. tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor. J Cardiovasc Pharmacol. 2000; 36(6):770-5.   DOI   ScienceOn
18 Hechler B, Magnenat S, Zighetti ML, Kassack MU, Ullmann H, Cazenave JP, et al. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriyl bis-(carbonylimino)))tetrakis-benzene-1,3-disulf onic acid octasodium salt]. J Pharmacol Exp Ther. 2005; 314(1):232-43.   DOI   ScienceOn
19 Sohn HY, Kwon CS, Son KH, Kwon GS, Rye HY, Kun EJ. Antithrombin and Thrombosis Prevention Activity of Buckwheat Seed, Fagopyrum esculentum Moench. J Korea Soc Food Sci Nutr. 2006; 35(2):132-8.   DOI
20 Yu JY, Jin YR, Lee JJ, Chung JH, Noh JY, You SH, et al. Antiplatelet and antithrombotic activities of Korean Red Ginseng. Arch Pharm Res. 2006; 29(10):898-903.   DOI   ScienceOn
21 Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie BC. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood. 2006; 107(10):3902-6.   DOI   ScienceOn
22 Heo J, Donguibogam. Yoon SH, Kim HJ, editors. Korea:Donguibogam Press. 2005:1147.
23 Min SH, Park HO, Oh HS. A study on the properties of water of Korean dried tangerine peel and development of beverage by using it. Korean J Soc Food Cookery Sci. 2002; 18(1):51-6.
24 Ji MS, Ko BS, Ahn SW, Kim JG. A bibliographical study on Jehotang. J East Asian Soc Dietary Life. 2008; 18(1): 158-64.
25 Ji MS, Kim JG. Analytical study on the Jehotang in Literature in terms of cooking science. J East Asian Soc Dietary Life. 2008; 18(4):446-54.
26 Ji MS, Park MJ, Lee MY, Kim JG , Ko BS. Effect of Jehotang extract on the growth of intestinal bacteria and immunostimulation. Korean J Food Sci Technol. 2006; 38: 104-8.
27 Jeon WK, Kim YE, Park SO, Kwon DY, Ahn SW, Lee JH, et al. The modified Jeho-tang, Korean herbal medicine, inhibits whole-blood aggregation and platelet adhesion to collagen under flow. Thromb Res. 2008; 122(6): 804-9.   DOI   ScienceOn
28 Kim SK, Jeon WK. Effects of Modified Jeho-tang on Ferric Chloride-induced Thrombosis in a Rat Model and of Peripheral Circulatory Disturbance in a Mouse Model. J Korean Soc Appl Biol Chem. 2010; 53(6): 842-6.   DOI   ScienceOn
29 Wang X, Smith PL, Hsu MY, Ogletree ML, Schumacher WA. Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor. J Thromb Haemost. 2006; 4(2): 403-10.   DOI   ScienceOn